AGRN Antikörper
-
- Target Alle AGRN Antikörper anzeigen
- AGRN (Agrin (AGRN))
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser AGRN Antikörper ist unkonjugiert
-
Applikation
- Immunohistochemistry (IHC), ELISA
- Aufreinigung
- Affinity purification
- Immunogen
- Synthetic peptide of human AGRN
- Isotyp
- IgG
- Top Product
- Discover our top product AGRN Primärantikörper
-
-
- Applikationshinweise
- IHC 1:50-1:200
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 0.3 mg/mL
- Buffer
- PBS with 0.05 % sodium azide and 50 % glycerol, PH7.4
- Konservierungsmittel
- Sodium azide
- Handhabung
- Avoid freeze / thaw cycles.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20°C. Avoid freeze / thaw cycles.
-
- Target
- AGRN (Agrin (AGRN))
- Andere Bezeichnung
- AGRN (AGRN Produkte)
- Synonyme
- AGRIN antikoerper, agrn antikoerper, wu:fb57e07 antikoerper, Agrin antikoerper, nmf380 antikoerper, AGR antikoerper, HSPG antikoerper, agrin antikoerper, LOC465392 antikoerper, agrn antikoerper, AGRN antikoerper, Agrn antikoerper
- Hintergrund
- AGRIN,Agrin proteoglycan,AGRN,FLJ45064,OTTHUMP00000044043,This gene encodes one of several proteins that are critical in the development of the neuromuscular junction (NMJ), as identified in mouse knock-out studies. The encoded protein contains several laminin G, Kazal type serine protease inhibitor, and epidermal growth factor domains. Additional post-translational modifications occur to add glycosaminoglycans and disulfide bonds. In one family with congenital myasthenic syndrome affecting limb-girdle muscles, a mutation in this gene was found.
- NCBI Accession
- NP_940978
- Pathways
- Glycosaminoglycan Metabolic Process, Regulation of Muscle Cell Differentiation, Skeletal Muscle Fiber Development
-